医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

InnoCare Announces First Subject Dosed in Clinical Trial of Novel Targeted Protein Degrader

InnoCare Announces First Subject Dosed in Clinical Trial of Novel Targeted Protein Degrader ICP-490 in China

ヘルスケア 腫瘍学 臨床試験　 TimeLine: ICP-490 in ChinaInnoCare Announces First Subject Dosed in Clinical Trial of Novel Targeted Protein Degrader

2023年04月04日